We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 526

Antitrust Alert: Medical Material Manufacturer Settles FTC Charges of Using Exclusive Contracts to Impede Competition
  • Jones Day
  • USA
  • May 10 2016

The U.S. Federal Trade Commission has made a settlement agreement with Invibio, Inc. ("Invibio"), a British-owned supplier of implant-grade polymer


Food, Dietary Supplement & Cosmetics Regulatory Update, Vol. III, Issue 7
  • Jones Day
  • Canada, China, European Union, USA
  • May 9 2016

On May 4, 2016, FDA announced that both the U.S. and Canada have recognized each other's food safety systems as comparable to each other. This is the


Pharmaceutical & Medical Device Regulatory Update Vol. III Issue 3
  • Jones Day
  • USA
  • May 6 2016

FDA released three new draft guidance documents regarding its implementation of the human drug compounding requirements of Title I of the Drug


IRS Denies Tax-Exempt Status to Non-MSSP ACO
  • Jones Day
  • USA
  • April 26 2016

Earlier this month, the IRS released a denial of an exemption application for an accountable care organization ("ACO") outside of the Medicare Shared


Food, Dietary Supplement & Cosmetics Regulatory Update, Vol. III, Issue 6
  • Jones Day
  • USA
  • April 14 2016

In early April 2016, FDA finalized the sixth major rule implementing the FDA Food Safety Modernization Act ("FSMA"). This latest rule, "Sanitary


Illinois Creates Health Care Fraud Elimination Task Force
  • Jones Day
  • USA
  • April 12 2016

On April 5, 2016, Illinois Governor Bruce Rauner signed Executive Order 16-05, creating a new Health Care Fraud Elimination Task Force to address


Pharmaceutical & Medical Device Regulatory Update, Vol. III, Issue 2
  • Jones Day
  • USA
  • April 8 2016

Earlier this week, FDA announced the availability of its long-awaited draft guidance on biosimilar labeling, titled "Labeling for Biosimilar Products


Digital Health Law Update, Vol. II, Issue 2
  • Jones Day
  • USA
  • April 6 2016

There is a saying making its way through the insurance marketplace that there are two types of companiesthose that already have purchased a cyber


Fourth Circuit Allows Lanham Act Unfair Competition Claims for Foreign Trademark Not Used in the U.S.
  • Jones Day
  • USA
  • March 30 2016

On March 23, the Fourth Circuit held that the owner of a Mexican trademark could bring false association and false advertising claims under


Food, Dietary Supplement & Cosmetics Regulatory Update, Vol. III, Issue 5
  • Jones Day
  • European Union, USA
  • March 24 2016

FDA recently announced a funding opportunity of $19M to states that support the implementation of the Food Safety Modernization Act ("FSMA") Produce